![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, August 16, 2020 1:30:19 PM
So they seem like the deep pockets here ...similar to the Baker Bros who helped fund Amarin's Reduce it trial in 2015 at around a $1 a share ( ran as high as $25 on FDA approval years later ) .
The current trials are not very large or expensive and the Chairman of the board maintains " we have sufficient access to capital to fund these studies on our own ".
Stock needs to trade above $4 to be listed on the NYSE or Naz ...I see no need for the Co to do a reverse split anytime soon if they can fund completion of the trials with existing access lines to capital ...and partner for the production scale up of RLF-100 and for distribution to hospitals .
Kiwi
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM